Form 4: Medpace Exec Exercises, Sells 10,000 Shares

Medpace Holdings Executive VP of Operations, Susan E. Burwig, exercised and sold 10,000 shares of common stock under a pre-arranged plan.

Summary

• Susan E. Burwig, Executive VP of Operations at Medpace Holdings, Inc., engaged in a transaction on December 2, 2025.
• Exercised employee stock options to acquire 10,000 shares of common stock at an exercise price of $107.93 per share.
• Simultaneously disposed of 10,000 shares of common stock at a price of $107.93 per share.
• The transaction was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following these transactions, Burwig beneficially owns 37,500 shares of common stock directly.
• Remaining derivative securities (employee stock options) beneficially owned total 20,984.

Sentiment

Score: 5

Explanation: The transaction is a routine exercise and sale of stock options by an executive under a pre-arranged 10b5-1 plan, which typically has a neutral sentiment impact as it's not indicative of new discretionary sentiment towards the company's prospects.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled, non-discretionary trade rather than a discretionary sale based on new information.

Negatives

• An executive sold 10,000 shares of common stock, which, while part of a pre-arranged plan, represents a reduction in direct shareholding.

Future Outlook

No specific future outlook or guidance is provided, as this filing reports a past insider transaction.

Industry Context

This transaction is an individual executive compensation event and does not directly relate to broader industry trends or competitive positioning, but rather reflects standard practices for managing executive equity awards.

Related Party Transactions

• The transaction involves an executive exercising and selling company stock, which is a standard compensation-related related party transaction.

Stakeholder Impact

• Shareholders may observe a reduction in direct shareholding by an executive, but this is mitigated by the transaction being part of a pre-arranged 10b5-1 plan.
• Employees: The transaction reflects standard executive compensation practices involving stock options.

Key Dates

Recommendation

The Form 4 filing details a pre-scheduled exercise and sale of stock options by an executive under a Rule 10b5-1 plan. Such transactions are generally considered routine and do not typically signal a change in the executive's discretionary view of the company's future prospects. Therefore, it does not provide new information that would significantly alter an investment recommendation based solely on this filing.

Keywords

Medpace Holdings, MEDP, Insider Trading, Form 4, Stock Option Exercise, Executive Compensation, Rule 10b5-1, Susan E. Burwig